Fingerprint
Dive into the research topics of 'Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: A phase 2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: A phase 2 study
Preetesh Jain, Hagop Kantarjian, Elias Jabbour, Graciela Nogueras Gonzalez, Gautam Borthakur, Naveen Pemmaraju, Naval Daver, Evguenia Gachimova, Alessandra Ferrajoli, Steven Kornblau, Farhad Ravandi, Susan O'Brien, Jorge Cortes
Research output: Contribution to journal › Article › peer-review
79
Scopus
citations